Luis A. Díaz

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Tumor microbial burden drives immune responses through regulation of Interferon signaling

  Cancer Discovery · 2026-06-26

• 2224-P: Optimal Age to Initiate Liver Fibrosis Screening in MASLD and Type 2 Diabetes

  Diabetes · 2026-06-05

• Implementation of <i>DPYD</i> genotyping in response to FDA black box warning: Initial experience at a comprehensive cancer center.

  Journal of Clinical Oncology · 2026-05-28

• Su2084 DISTINCT DRIVERS OF SEVERE STEATOSIS ACROSS THE LIFESPAN: DISPROPORTIONATE INSULIN RESISTANCE IN ADOLESCENTS AND A DOUBLE-HIT METABOLIC-ALCOHOL PHENOTYPE IN YOUNG ADULTS

  Gastroenterology · 2026-05-01

• Mo2019 IMPACT OF DYNAMIC CHANGES IN VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY ON LIVER-RELATED EVENTS IN STEATOTIC LIVER DISEASE

  Gastrointestinal Endoscopy · 2026-05-01

• Su2051 STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE: A RETROSPECTIVE ANALYSIS AND FIB-4 PERFORMANCE

  Gastroenterology · 2026-05-01

• Su2044 METABOLIC PHENOTYPES FOR RISK STRATIFICATION OF SIGNIFICANT LIVER FIBROSIS IN THE LEAN POPULATION WITH MASLD

  Gastroenterology · 2026-05-01

• Tu2101 IMPACT OF STEATOTIC LIVER DONORS ON RECIPIENTS WITH STEATOTIC LIVER DISEASE: A UNITED STATES ANALYSIS OF THE LAST DECADE

  Gastroenterology · 2026-05-01

• Su2046 METABOLIC DYSFUNCTION MARKERS OUTPERFORM IN YOUTH: AGE-STRATIFIED DIAGNOSTIC THRESHOLDS FOR STEATOTIC LIVER DISEASE IN U.S. ADOLESCENTS AND YOUNG ADULTS

  Gastroenterology · 2026-05-01

• Tu2138 ETIOLOGY - SPECIFIC PATTERNS OF POST-TRANSPLANT MALIGNANCY IN LIVER TRANSPLANT RECIPIENTS

  Gastroenterology · 2026-05-01

• Su2128 PNPLA3 G-RISK ALLELE IS ASSOCIATED WITH MAJOR-ADVERSE LIVER-RELATED OUTCOMES (MALO) EVEN WHEN ADJUSTING FOR FIBROSIS LEVEL IN A PROSPECTIVELY RECRUITED COHORT OF PARTICIPANTS AT-RISK OR DIAGNOSED WITH MASLD

  Gastrointestinal Endoscopy · 2026-05-01

• Mo2028 PREVALENCE OF ALCOHOL USE AMONG PATIENTS WITH CIRRHOSIS IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY

  Gastroenterology · 2026-05-01

• Su2036 NONINVASIVE TEST CONCORDANCE ENHANCES PREDICTION OF MAJOR ADVERSE LIVER OUTCOMES IN MASLD

  Gastroenterology · 2026-05-01

• Mo2030 ADJUNCTIVE N-ACETYLCYSTINE WITH CORTICOSTEROIDS DOES NOT IMPROVE OUTCOMES IN ALCOHOL-ASSOCIATED HEPATITIS

  Gastrointestinal Endoscopy · 2026-05-01

• Su2036 NONINVASIVE TEST CONCORDANCE ENHANCES PREDICTION OF MAJOR ADVERSE LIVER OUTCOMES IN MASLD

  Gastrointestinal Endoscopy · 2026-05-01

• Mo2030 ADJUNCTIVE N-ACETYLCYSTINE WITH CORTICOSTEROIDS DOES NOT IMPROVE OUTCOMES IN ALCOHOL-ASSOCIATED HEPATITIS

  Gastroenterology · 2026-05-01

• Su2033 PHOSPHATIDYLETHANOL (PETH) BETTER PREDICTS HEPATIC STEATOSIS THAN SELF-REPORTED ALCOHOL CONSUMPTION AMONG INDIVIDUALS WITH OVERWEIGHT AND OBESITY

  Gastroenterology · 2026-05-01

• Su2044 METABOLIC PHENOTYPES FOR RISK STRATIFICATION OF SIGNIFICANT LIVER FIBROSIS IN THE LEAN POPULATION WITH MASLD

  Gastrointestinal Endoscopy · 2026-05-01

• Su2128 PNPLA3 G-RISK ALLELE IS ASSOCIATED WITH MAJOR-ADVERSE LIVER-RELATED OUTCOMES (MALO) EVEN WHEN ADJUSTING FOR FIBROSIS LEVEL IN A PROSPECTIVELY RECRUITED COHORT OF PARTICIPANTS AT-RISK OR DIAGNOSED WITH MASLD

  Gastroenterology · 2026-05-01

• 1263 PERFORMANCE AND RISK OF FALSE NEGATIVES IN CLINICAL PATHWAYS TO IDENTIFY ADVANCED FIBROSIS IN METALD AND ALD

  Gastrointestinal Endoscopy · 2026-05-01